Detalhe da pesquisa
1.
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.
Br J Haematol
; 201(5): 865-873, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866733
2.
Zanubrutinib for the treatment of Waldenström Macroglobulinemia.
Expert Rev Hematol
; 13(12): 1303-1310, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297772
3.
An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia.
Expert Opin Pharmacother
; 21(13): 1555-1564, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603202
4.
Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of 'real-world' experience from Western Australia.
Leuk Lymphoma
; 60(14): 3417-3425, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31304820
5.
Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?
Lancet Haematol
; 10(12): e942-e943, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922924
6.
Detection of an IGH-BRAF fusion in a patient with BRAF Val600Glu negative hairy cell leukemia.
Leuk Lymphoma
; 61(8): 2024-2026, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319330